Design and run studies that reveal actionable biology in tumors.
Take part in oncology drug target assessment using Gordion’s tumor analysis platform, combining your understanding of cancer genomics, genes, and pathways driving cancer.
Work with genomic data (NGS, WGS, RNAseq) and large-scale datasets (DepMap, TCGA, ICGC).
Translate data into insights that drive target discovery and biomarker identification.
Collaborate with external partners to help assess drug mechanisms, identify biomarkers, and strengthen their oncology programs.
Work closely with a small, ambitious team where ideas move fast and impact is immediate.
What we’re looking for:
Ph.D. in Cancer Biology or a related field.
Solid background in cancer genomics and an understanding of the genes and pathways driving cancer.
Experience with bioinformatics tools and genomic data analysis (NGS, WGS, RNAseq).
Comfortable working with large datasets such as DepMap, TCGA, and ICGC.
Strong analytical and problem-solving skills with a good sense for experimental design and data interpretation.
A clear communicator who enjoys working collaboratively, is curious, and open-minded.
What We Offer:
Work that lets you see the impact of your science, from data to real decisions in oncology drug discovery.
A chance to join a small, driven team where your ideas shape both our technology and our partnerships.
An environment built on trust, curiosity, and open collaboration, where every contribution truly matters.
Competitive compensation, solid benefits, and the opportunity to grow with a company that values learning and initiative.
This position is based in Europe, with flexible working options including remote and on-site collaboration
